Newsgather

cholesterol

مستقر11 خبر8 مصادرآخر تحديث: 3 g önce

أحدث الأخبار

Four Health Markers That May Offer a Broader Understanding of Cardiovascular Risk
صحة
03.06.2026ملخص الذكاء الاصطناعي

Four Health Markers That May Offer a Broader Understanding of Cardiovascular Risk

Cardiologists suggest focusing on four markers beyond LDL cholesterol for a comprehensive cardiovascular risk assessment: ApoB, hs-CRP, insulin resistance, and abdominal obesity. These factors provide insights into harmful particle counts, inflammation, metabolism, and fat distribution, aiding earlier detection of potential heart attacks and strokes.

T
Times of India
Being Young And Fit No Longer Protects You From High Cholesterol: Doctor Shares Prevention Tips
يتطور
صحة·28.04.2026ملخص الذكاء الاصطناعي

Being Young And Fit No Longer Protects You From High Cholesterol: Doctor Shares Prevention Tips

Abnormal cholesterol is emerging as a silent epidemic among young Indians, with 25-30% of urban youth and 15-20% of rural youth already having elevated levels. Nearly one in five at-risk individuals remain undiagnosed. A 2026 study shows nearly two in five Indian adolescents have dyslipidemia, with low HDL being the most prevalent abnormality. Dr R Govindarajan advises baseline lipid screening between ages 20-25, daily movement, and fiber-rich nutrition as prevention strategies.

T
Times of India
Pharma Bets Big on Lp(a) Cholesterol Drugs With $5.6B Market Potential
يتطور
صحة·27.04.2026ملخص الذكاء الاصطناعي

Pharma Bets Big on Lp(a) Cholesterol Drugs With $5.6B Market Potential

Novartis, Amgen and Eli Lilly are in late-stage trials for drugs targeting Lp(a), a dangerous form of cholesterol affecting one in five people worldwide. Novartis expects Phase 3 results mid-2026 for pelacarsen, with Amgen and Lilly following in 2027 and 2029. The drugs have shown 80%+ Lp(a) reduction but must now prove clinical benefit. If successful, the market could reach $5.6B by 2032, though less than 1% of U.S. adults currently get tested for Lp(a).

C
CNBC